Align Technology, Inc. Share Price

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
309 USD -0.48% Intraday chart for Align Technology, Inc. +3.36% +12.78%
Sales 2024 * 4.12B 343B Sales 2025 * 4.52B 377B Capitalization 23.25B 1,939B
Net income 2024 * 539M 44.94B Net income 2025 * 638M 53.2B EV / Sales 2024 * 5.33 x
Net cash position 2024 * 1.32B 110B Net cash position 2025 * 1.52B 127B EV / Sales 2025 * 4.81 x
P/E ratio 2024 *
43.3 x
P/E ratio 2025 *
36.4 x
Employees 21,610
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.48%
1 week+3.36%
Current month-5.76%
1 month-5.76%
3 months+16.93%
6 months+61.84%
Current year+12.78%
More quotes
1 week
297.17
Extreme 297.17
327.49
1 month
296.50
Extreme 296.5
331.64
Current year
250.28
Extreme 250.28
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 01/15/01
Director of Finance/CFO 57 10/16/10
Chief Tech/Sci/R&D Officer 59 02/13/02
Members of the board TitleAgeSince
Director/Board Member 72 01/06/01
Chief Executive Officer 65 01/15/01
Director/Board Member 58 05/12
More insiders
Date Price Change Volume
26/24/26 309 -0.48% 737,294
25/24/25 310.5 -1.05% 1,654,540
24/24/24 313.8 +0.61% 1,106,124
23/24/23 311.9 +3.68% 621,458
22/24/22 300.8 +0.62% 446,836

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
309 USD
Average target price
335.2 USD
Spread / Average Target
+8.48%
Consensus